Skip to content

Gastroesophageal Reflux Disease in Azerbaijan

The Prevalence of Gastroesophageal Reflux Disease in Azerbaijan

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03616119
Enrollment
1000
Registered
2018-08-06
Start date
2018-01-01
Completion date
2019-09-01
Last updated
2022-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Keywords

gastoesophageal reflux disease, prevalence, Azerbaijan

Brief summary

To evaluate the prevalence of Gastroesophageal reflux disease in Azerbaijan. It is intended to evaluate the prevalence of the disease in the regions as well as the capital by cluster sampling ,ethitology and to compare the outcomes depending on the geographical location.

Detailed description

It is an observational, nationwide study. The GERD questionnaire (1994) requested from Mayo clinic, was received and validated. The questionnaire was translated by 3 individuals from english to azeri and back trasnlated by 3 native english speakers. Power analysis was performed. The research was presented for the approval to Ethical Committee of Azerbaijan Medical University. Prior to the actual study, a pilot study with smaller number of participants was performed and the results were evaluated. Cluster sampling methodology was provided by the statistical department of Azerbaijan Medical University. 110 employees were hired for using a survey in different regions of Azerbaijan. Written consent was obtained from every person evaluated. Statistical ananlysis was performed.

Interventions

None listed

Sponsors

Azerbaijan Medical University
CollaboratorOTHER
Sevda Aghayeva
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18-80 * Both genders * Hearburn * Belching * Regurgitation

Exclusion criteria

* protom pomp inhibitor use * antibiotic use in the last 4 weeks * upper GI surgery

Design outcomes

Primary

MeasureTime frameDescription
The prevalence of GERD in Azerbaijan1 yearThe prevalence of GERD in Azerbaijan was 22.7% with significant female predominance (26.1% vs 15.3%; p\<0.0001). GERD was defined in 17 % for ages below 35; 22.7 % for 36-55 and 38.5 % for those who are above 56 that, accordingly, indicating that GERD becomes significant as age increases (p\<0.0001). Reflux was observed in 18.1% of normal weight respondents (BMI 18.6-24.9), 25.6% of overweight (BMI 25-29.9), and in 30.4% of obese (BMI\>30) individuals (p=0.001). Regarding marital status, the prevalence was the lowest in the single subjects' group (17%), close to average in the married group (23.8%), and the highest (41.7%) in divorced/widowed cases (p=0.003). Stress was significantly affecting GERD distribution, affecting 59.4% of all respondents (p\<0.004).
GERD questionnaire (GERD) of Mayo case 1998- 0191 yearObservational study

Countries

Azerbaijan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026